雷特鲁肽与安慰剂和度拉鲁肽在减轻体重和糖尿病管理方面的对比分析：临床试验的启示。

{"title":"雷特鲁肽与安慰剂和度拉鲁肽在减轻体重和糖尿病管理方面的对比分析：临床试验的启示。","authors":"Hazem Ayesh, Suhail Ayesh, Kevin Niswender","doi":"10.1097/MJT.0000000000001743","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"31 4","pages":"e523-e527"},"PeriodicalIF":2.9000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparative Meta-Analysis of Retatrutide Versus Placebo and Dulaglutide for Weight Loss and Diabetes Management: Insights From Clinical Trials.\",\"authors\":\"Hazem Ayesh, Suhail Ayesh, Kevin Niswender\",\"doi\":\"10.1097/MJT.0000000000001743\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":7760,\"journal\":{\"name\":\"American journal of therapeutics\",\"volume\":\"31 4\",\"pages\":\"e523-e527\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/MJT.0000000000001743\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MJT.0000000000001743","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}